BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758
130 results:

  • 1. Investigation of iso-propylchaetominine anticancer activity on apoptosis, cell cycle and Wnt signaling pathway in different cancer models.
    Karamad V; Sogutlu F; Ozkaya FC; Shademan B; Ebrahim W; El-Neketi M; Avci CB
    Fitoterapia; 2024 Mar; 173():105789. PubMed ID: 38158162
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways.
    Ciummo SL; Sorrentino C; Fieni C; Di Carlo E
    J Exp Clin Cancer Res; 2023 Dec; 42(1):336. PubMed ID: 38087324
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Vegetarian diets and risk of all-cause mortality in a population-based prospective study in the United States.
    Blackie K; Bobe G; Takata Y
    J Health Popul Nutr; 2023 Nov; 42(1):130. PubMed ID: 37996932
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Development and validation of a nomogram to predict cancer-specific survival in nonsurgically treated elderly patients with prostate cancer.
    Zhang Z; Cai Q; Wang J; Yao Z; Ji F; Hang Y; Ma J; Jiang H; Yan B; Zhanghuang C
    Sci Rep; 2023 Oct; 13(1):17719. PubMed ID: 37853026
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. 5-alpha reductase inhibitors (5-ARi) with or without alpha-blockers (α-B) for Benign Prostatic Hyperplasia do NOT lower the risk of incident Bladder cancer: United States insurance claims data.
    Del Giudice F; Belladelli F; Glover F; Basran S; Li S; Mulloy E; Pradere B; Soria F; Krajewski W; Nair R; Muncey W; Seranio N; Eisenberg ML
    World J Urol; 2023 Oct; 41(10):2783-2791. PubMed ID: 37548746
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Assessment of bone-targeting agents use in patients with bone metastasis from breast, lung or prostate cancer using structured and unstructured electronic health records from a regional UK-based hospital.
    Seesaghur A; Egger P; Warden J; Abbasi A; Levick B; Riaz M; McMahon P; Thompson M; Cheeseman S
    BMJ Open; 2023 May; 13(5):e069214. PubMed ID: 37156580
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Visual Analogue Scale and Expanded prostate cancer Index Composite-26 in the Evaluation of Urinary Continence Recovery After Three-Dimensional Laparoscopic Radical prostatectomy, a Single-Center Prospective Registered Study.
    Valli J; Haapiainen H; Murtola TJ; Huhtala H; Kaipia A; Raitanen M
    Urology; 2023 Jul; 177():103-108. PubMed ID: 37146729
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Are high-risk prostate cancer patients being treated equally? The impact of PSA.
    Kord E; Ferenczi B; DiNatale RG; Daily A; Koenig H; Frankel J; Jung N; Flores JP; Porter C
    Urol Oncol; 2023 Apr; 41(4):204.e17-204.e25. PubMed ID: 36918337
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. cancer survival in the northwestern of São Paulo State, Brazil: A population-based study.
    Mafra A; Bardot A; Charvat H; Weiderpass E; Soerjomataram I; Fregnani JHTG
    Cancer Epidemiol; 2023 Apr; 83():102339. PubMed ID: 36863216
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A comprehensive gene expression profile analysis of prostate cancer cells resistant to paclitaxel and the potent target to reverse resistance.
    Che P; Jiang S; Zhang W; Zhu H; Hu D; Wang D
    Hum Exp Toxicol; 2022; 41():9603271221129854. PubMed ID: 36165000
    [No Abstract]    [Full Text] [Related]  

  • 11. Association between prior cancer diagnosis and osteoporosis: a matched case-control study.
    Yang S; Wang N; Wang J; Lix LM; Leslie WD; Yuan B
    Arch Osteoporos; 2022 Aug; 17(1):112. PubMed ID: 35960383
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Retzius-Sparing
    Turkolmez K; Akpinar C; Kubilay E; Suer E
    J Endourol; 2022 Sep; 36(9):1214-1222. PubMed ID: 35546454
    [No Abstract]    [Full Text] [Related]  

  • 13. Analysis of adverse event of interstitial lung disease in men with prostate cancer receiving hormone therapy using the Food and Drug Administration Adverse Event Reporting System.
    Wu B; Shen P; Yin X; Yu L; Wu F; Chen C; Li J; Xu T
    Br J Clin Pharmacol; 2023 Feb; 89(2):440-448. PubMed ID: 35349180
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Application of Shear Wave Elastography and Contrast-Enhanced Ultrasound in Transrectal prostate Biopsy.
    Sharen GW; Zhang J
    Curr Med Sci; 2022 Apr; 42(2):447-452. PubMed ID: 35301673
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Survival after radical prostatectomy versus radiation therapy in clinical node-positive prostate cancer.
    Chierigo F; Borghesi M; Würnschimmel C; Flammia RS; Horlemann B; Sorce G; Hoeh B; Tian Z; Saad F; Graefen M; Gallucci M; Briganti A; Montorsi F; Chun FKH; Shariat SF; Mantica G; Suardi N; Terrone C; Karakiewicz PI
    Prostate; 2022 May; 82(6):740-750. PubMed ID: 35226380
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Assessment of Regional Variability in COVID-19 Outcomes Among Patients With cancer in the United States.
    Hawley JE; Sun T; Chism DD; Duma N; Fu JC; Gatson NTN; Mishra S; Nguyen RH; Reid SA; Serrano OK; Singh SRK; Venepalli NK; Bakouny Z; Bashir B; Bilen MA; Caimi PF; Choueiri TK; Dawsey SJ; Fecher LA; Flora DB; Friese CR; Glover MJ; Gonzalez CJ; Goyal S; Halfdanarson TR; Hershman DL; Khan H; Labaki C; Lewis MA; McKay RR; Messing I; Pennell NA; Puc M; Ravindranathan D; Rhodes TD; Rivera AV; Roller J; Schwartz GK; Shah SA; Shaya JA; Streckfuss M; Thompson MA; Wulff-Burchfield EM; Xie Z; Yu PP; Warner JL; Shah DP; French B; Hwang C;
    JAMA Netw Open; 2022 Jan; 5(1):e2142046. PubMed ID: 34982158
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Incorporating artificial intelligence in urology: Supervised machine learning algorithms demonstrate comparative advantage over nomograms in predicting biochemical recurrence after prostatectomy.
    Tan YG; Fang AHS; Lim JKS; Khalid F; Chen K; Ho HSS; Yuen JSP; Huang HH; Tay KJ
    Prostate; 2022 Feb; 82(3):298-305. PubMed ID: 34855228
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinical Significance and Underlying Mechanisms of CELSR3 in Metastatic prostate cancer Based on Immunohistochemistry, Data Mining, and
    Sun Y; Chen G; He J; Li JX; Gan XY; Ji SF; Huang Y; Chen XH; He ML; Huang ZG
    Cancer Biother Radiopharm; 2022 Aug; 37(6):466-479. PubMed ID: 34582697
    [No Abstract]    [Full Text] [Related]  

  • 19. The current recommendation for the management of isolated high-grade prostatic intraepithelial neoplasia.
    Morote J; Schwartzmann I; Celma A; Roche S; de Torres IM; Mast R; Semidey ME; Regis L; Santamaria A; Planas J; Trilla E
    BJU Int; 2022 May; 129(5):627-633. PubMed ID: 34375498
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Diagnostic performance of deep learning models for detecting bone metastasis on whole-body bone scan in prostate cancer.
    Han S; Oh JS; Lee JJ
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):585-595. PubMed ID: 34363089
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.